BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Treatment
330 results:

  • 1. Circular RNA circTATDN3 promotes the Warburg effect and proliferation in colorectal cancer.
    Lin J; Zhong W; Lyu Z; Peng J; Rong Y; Zeng K; Lai J; Wu D; Wang J; Li Y; Zheng J; Zhang J; Pan Z
    Cancer Lett; 2024 May; 589():216825. PubMed ID: 38548218
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Transcriptomic screening of novel targets of sericin in human hepatocellular carcinoma cells.
    Jantaravinid J; Tirawanchai N; Ampawong S; Kengkoom K; Somkasetrin A; Nakhonsri V; Aramwit P
    Sci Rep; 2024 Mar; 14(1):5455. PubMed ID: 38443583
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway.
    Ci M; Zhao G; Li C; Liu R; Hu X; Pan J; Shen Y; Zhang G; Li Y; Zhang L; Liang P; Cui H
    Cell Death Dis; 2024 Mar; 15(3):179. PubMed ID: 38429268
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma.
    Demir S; Razizadeh N; Indersie E; Branchereau S; Cairo S; Kappler R
    Hepatol Commun; 2024 Feb; 8(2):. PubMed ID: 38285887
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Heterogeneity-induced NGF-NGFR communication inefficiency promotes mitotic spindle disorganization in exhausted T cells through PREX1 suppression to impair the anti-tumor immunotherapy with PD-1 mAb in hepatocellular carcinoma.
    Wang X; Yang T; Shi S; Xu C; Wang F; Dai D; Guan G; Zhang Y; Wang S; Wang J; Zhang B; Liu P; Bai X; Jin Y; Li X; Zhu C; Chen D; Xu Q; Guo Y
    Cancer Med; 2024 Feb; 13(3):e6736. PubMed ID: 38204220
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. BAP18 acting as a novel peroxisome proliferator-activated receptor α co-regulator contributes to hepatocellular carcinoma progression.
    Liu W; Wang S; Lin L; Zou R; Sun H; Zeng K; Wu Y; Li Y; Shigeaki K; Wang X; Wang C; Zhao Y
    Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166974. PubMed ID: 38042310
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. (S)-3-(3-Fluoro-4-Methoxybenzyl)-5,6,7-Trimethoxychroman-4-One Suppresses the Proliferation of Huh7 Cells by Up-regulating P21 and Inducing G
    Yoon H; Lee J; Kwon S; Seo SY; Cho S
    Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):754-762. PubMed ID: 38035711
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. EZH2 is a key component of hepatoblastoma tumor cell growth.
    Glaser K; Schepers EJ; Zwolshen HM; Lake CM; Timchenko NA; Karns RA; Cairo S; Geller JI; Tiao GM; Bondoc AJ
    Pediatr Blood Cancer; 2024 Feb; 71(2):e30774. PubMed ID: 37990130
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Molecular, Immunologic, and Clinicodemographic Landscape of MYC-Amplified Advanced Prostate cancer.
    Jin WH; Zhang L; Graf R; Raskina K; Tukachinsky H; Huang RSP; McGregor K; Alshalalfa M; Hougen HY; Khan A; Punnen S; Schrock AB; Venstrom J; Mahal BA
    Clin Genitourin Cancer; 2024 Feb; 22(1):e163-e169.e1. PubMed ID: 37978032
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Insight into the design of FGFR4 selective inhibitors in cancer therapy: Prospects and challenges.
    Chen X; Huang Y; Chen B; Liu H; Cai Y; Yang Y
    Eur J Med Chem; 2024 Jan; 263():115947. PubMed ID: 37976704
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Development and validation a radiomics nomogram for predicting thymidylate synthase status in hepatocellular carcinoma based on Gd-DTPA contrast enhanced MRI.
    Ding Z; Wu Y; Fang G; Lin Z; Lin K; Fu J; Huang Q; Tang Y; You W; Liu J; Zeng Y
    BMC Cancer; 2023 Oct; 23(1):991. PubMed ID: 37848807
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Suberoylanilide hydroxamic acid upregulates reticulophagy receptor expression and promotes cell death in hepatocellular carcinoma cells.
    Li JY; Tian T; Han B; Yang T; Guo YX; Wu JY; Chen YS; Yang Q; Xie RJ
    World J Gastroenterol; 2023 Sep; 29(34):5038-5053. PubMed ID: 37753370
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The ALKBH5/SOX4 axis promotes liver cancer stem cell properties via activating the SHH signaling pathway.
    Yang Q; Liang Y; Shi Y; Shang J; Huang X
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15499-15510. PubMed ID: 37646828
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Discovery of Novel 1,2,3,4-Tetrahydrobenzofuro[2,3-
    Lai Z; Ni H; Hu X; Cui S
    J Med Chem; 2023 Aug; 66(15):10791-10807. PubMed ID: 37498552
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. B7-H3 but not PD-L1 is involved in the antitumor effects of Dihydroartemisinin in non-small cell lung cancer.
    Hu BQ; Huang JF; Niu K; Zhou J; Wang NN; Liu Y; Chen LW
    Eur J Pharmacol; 2023 Jul; 950():175746. PubMed ID: 37105515
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.
    Chatzipanagiotou O; Schizas D; Vailas M; Tsoli M; Sakarellos P; Sotiropoulou M; Papalambros A; Felekouras E
    J Neuroendocrinol; 2023 Apr; 35(4):e13267. PubMed ID: 37042078
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Development of mouse models with restricted HLA-B∗57:01 presentation for the study of flucloxacillin-driven T-cell activation and tolerance in liver injury.
    Ananthula S; Krishnaveni Sivakumar K; Cardone M; Su S; Roderiquez G; Abuzeineh H; Kleiner DE; Norcross MA; Puig M
    J Allergy Clin Immunol; 2023 Aug; 152(2):486-499.e7. PubMed ID: 37030592
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. FOXM1 augments sorafenib resistance and promotes progression of hepatocellular carcinoma by epigenetically activating KIF23 expression.
    Zhu C; Guo H; Ma Z; Shi S; Zhao X; Zhai D; Zhou X; Jiang P; Xu Q; Cai J
    Biochem Biophys Res Commun; 2023 May; 656():1-9. PubMed ID: 36940637
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Sulforaphane Potentiates Gemcitabine-Mediated Anti-cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity.
    Tomooka F; Kaji K; Nishimura N; Kubo T; Iwai S; Shibamoto A; Suzuki J; Kitagawa K; Namisaki T; Akahane T; Mitoro A; Yoshiji H
    Cells; 2023 Feb; 12(5):. PubMed ID: 36899823
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Is DFT Accurate Enough to Calculate Regioselectivity? The Case of 1,3-Dipolar Cycloaddition of Azide to Alkynes and Alkenes.
    Molteni G; Ponti A
    Chemphyschem; 2023 Jun; 24(12):e202300114. PubMed ID: 36896728
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 17.